TransCon™: an innovative technology platform addressing unmet medical need
Yesterday evening, BioRNLounge attendees had the opportunity to take a deeper look at Ascendis Pharma and its technology platform TransCon™.
Thanks again for the great presentation Andreas Philipp Boudier.
Many scientific questions stimulated discussion over pizza and drinks - it was once again a great event with lively conversations and a high level of networking among the participants.
Did you know that the TransCon™ technology platform was developed in Heidelberg and Ascendis Pharma still operates its R&D lab facility in Heidelberg?
This is on a growth course - a positive signal for our growing Life Science ecosystem.